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yoﬁbroblasts are specialized ﬁbroblasts responsible
 
for granulation tissue contraction and the soft tissue
 
retractions occurring during ﬁbrocontractive diseases.
The marker of ﬁbroblast-myoﬁbroblast modulation is the
 
neo expression of 
 
 
 
–smooth muscle actin (
 
 
 
-SMA), the
actin isoform typical of vascular smooth muscle cells that
has been suggested to play an important role in myoﬁbroblast
 
force generation. Actin isoforms differ slightly in their NH
 
2
 
-
terminal sequences; these conserved differences suggest
 
different functions. When the NH
 
2
 
-terminal sequence of
 
 
 
-SMA Ac-EEED is delivered to cultured myoﬁbroblast in
the form of a fusion peptide (FP) with a cell penetrating
sequence, it inhibits their contractile activity; moreover,
M
 
upon topical administration in vivo it inhibits the contrac-
tion of rat wound granulation tissue. The NH
 
2
 
-terminal
peptide of 
 
 
 
–skeletal actin has no effect on myoﬁbroblasts,
whereas the NH
 
2
 
-terminal peptide of 
 
 
 
–cytoplasmic actin
abolishes the immunoﬂuorescence staining for this isoform
 
without inﬂuencing 
 
 
 
-SMA distribution and cell contraction.
The FPs represent a new tool to better understand the
speciﬁc functions of actin isoforms. Our ﬁndings support the
crucial role of 
 
 
 
-SMA in wound contraction. The 
 
 
 
-SMA–FP
will be useful for the understanding of the mechanisms of
 
connective tissue remodeling; moreover, it furnishes the basis
for a cytoskeleton-dependent preventive and/or therapeutic
strategy for ﬁbrocontractive pathological situations.
 
Introduction
 
Myofibroblasts (Gabbiani et al., 1971; Majno et al., 1971)
are specialized fibroblasts considered to be responsible for
granulation tissue contraction (Martin, 1997) and soft tissue
retractions typical of fibrocontractive diseases (Grinnell,
1994; Serini and Gabbiani, 1999). Their main activities are
synthesis and remodeling of the extracellular matrix and
generation of tensile force (Serini and Gabbiani, 1999).
Acquisition of contractile properties by the myofibroblast is
reflected in the neo expression of 
 
 
 
–smooth muscle actin
(
 
 
 
-SMA),* the actin isoform typical of vascular smooth
muscle (SM) cells (Skalli et al., 1986; Darby et al., 1990)
and, albeit less frequently, of other SM cell-specific proteins
(e.g., SM myosin heavy chains, desmin, and caldesmon)
(Serini and Gabbiani, 1999). The mechanisms of force gen-
eration by the myofibroblast are unknown presently but are
clearly different than those playing a role in classical striated
and SM contraction (Grinnell, 2000; Parizi et al., 2000). It
is accepted that they depend on the formation and contrac-
tion of stress fibers (Burridge, 1981; Tomasek et al., 1992;
Katoh et al., 1998), organelles typical of cultured fibroblasts,
and of myofibroblasts in vivo (Serini and Gabbiani, 1999).
The expression of 
 
 
 
-SMA in stress fibers increases the con-
tractile activity of fibroblastic cells in vitro (Arora and
McCulloch, 1994; Hinz et al., 2001a) and correlates with
wound contraction efficiency in vivo (Darby et al., 1990;
Hinz et al., 2001b). Actin, a major protein in all eukaryotic
cells, is expressed in mammalian species as six cell type-spe-
cific isoforms. These isoforms show very small but conserved
sequence differences (Vandekerckhove and Weber, 1978);
their specific functions are presently not established. Actin iso-
 
forms differ essentially in their NH
 
2
 
 terminus (Vandekerckhove
and Weber, 1978); thus, this domain represents a likely
candidate for specialized functions mediated through spe-
cific binding. The NH
 
2
 
-terminal sequence Ac-EEED (the
epitope of the monoclonal antibody directed against 
 
 
 
-SMA)
(Skalli et al., 1986; Chaponnier et al., 1995) appears to be
important for 
 
 
 
-SMA polymerization and incorporation in
stress fibers (Chaponnier et al., 1995). When microinjected
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into cultured fibroblasts, Ac-EEED produces the disappear-
ance of 
 
 
 
-SMA–specific immunodetection (Chaponnier et
al., 1995), suggesting that it interferes with the function of
this isoform. To verify whether the effects of peptide deliv-
ery include functional changes in myofibroblast activities,
we have constructed a fusion peptide (FP; SMA-FP) includ-
ing Ac-EEED and the Antennapedia third helix sequence
(pAntp-Pro50) (Derossi et al., 1994) that allows cell pene-
tration. We show here that the SMA-FP localizes in stress fi-
bers rapidly after its delivery; it then inhibits contractility of
myofibroblasts in vitro and granulation tissue contraction in
vivo, thus supporting the assumption that 
 
 
 
-SMA plays an
important role in wound contraction.
 
Results
 
SMA-FP and the similarly constructed control 
 
 
 
–skeletal
actin (
 
 
 
-SKA) FP (SKA-FP), consisting of the NH
 
2
 
-termi-
nal peptide of 
 
 
 
-SKA Ac-DEDE plus the vector pAntp-
Pro50 (Derossi et al., 1994), were synthesized either with-
out or with rhodamine (Rh) B labeling (SMA-Rh-FP and
SKA-Rh-FP); when tested, labeling did not change FP ac-
tivity (unpublished data). The 
 
 
 
–cytoplasmic actin FP
(
 
 
 
-CA–FP) was synthesized without Rh B labeling. We se-
lected these controls because (a) the NH
 
2
 
-terminal se-
quence of 
 
 
 
-SKA is the closest to that of 
 
 
 
-SMA and (b)
 
 
 
-CA is highly expressed in myofibroblasts. When added
to cultured rat lung fibroblasts (LFs) that express high lev-
els of 
 
 
 
-SMA (Hinz et al., 2001a), the control SKA-Rh-FP
showed within a few minutes a diffuse cytoplasmic distri-
bution (Fig. 1 A) and had no effect on the immunostaining
of 
 
 
 
-SMA (Fig. 1 B) and 
 
 
 
-CA (Fig. 1 C). SMA-Rh-FP
entered LFs similarly to SKA-Rh-FP but localized specifi-
cally in stress fibers (Fig. 1 D); the staining of stress fibers
by the 
 
 
 
-SMA–specific antibody gradually decreased over
30 min (Fig. 1 E), whereas staining for 
 
 
 
-CA remained un-
changed (Fig. 1 F). After washing, the SMA-Rh-FP disap-
peared from stress fibers, and 
 
 
 
-SMA staining was restored
over 30–60 min (unpublished data). These results suggest
that Ac-EEED reversibly binds to a specific partner located
in stress fibers. When the 
 
 
 
-CA–FP was added to cultured
LFs, it produced a gradual disappearance of 
 
 
 
-CA from
stress fibers over 30 min (Fig. 2 E) without any change in
 
 
 
-SMA distribution (Fig. 2 D); moreover, large cytoplas-
mic protrusions devoid of filamentous 
 
 
 
-CA and 
 
 
 
-SMA
appeared regularly at the periphery of these cells (Fig. 2 F),
suggesting that 
 
 
 
-CA–FP modifies cellular shape by affect-
ing the cortical network (Fig. 2).
To investigate the effect of SMA-FP on individual myofibro-
blasts, LFs were grown on deformable silicone substrates (Har-
Figure 1. Distribution of FPs in cultured 
LFs and their action on  -SMA immu-
nostaining. SKA-Rh-FP (A, red) shows 
diffuse cytoplasmic distribution 30 min 
after application to the culture medium. 
At the same time, it does not affect the 
staining for  -SMA (B, green) and  -CA 
(C, blue) in stress fibers. Under the same 
conditions, SMA-Rh-FP localizes along 
stress fibers (D) and abolishes  -SMA 
staining (E) without changing the staining 
for  -CA (F). Bar, 50  m.
Figure 2. Effect of the  -CA–FP on 
cultured LFs. Control LFs coexpress 
 -SMA (A, green) and  -CA (B, red) in 
stress fibers (C, yellow). When added 
to cultured LFs for 30 min, the  -CA–FP 
does not affect the staining for  -SMA 
(D) but abolishes staining for  -CA (E). 
Moreover,  -CA–FP induces the de novo 
formation of lamellar protrusions that 
are free of stress fibers (F, white line 
indicates putative cell edge before 
treatment). Bar, 50  m. 
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ris et al., 1980), which were produced with a stiffness that re-
stricts the formation of wrinkles to highly contractile 
 
 
 
-SMA–
positive fibroblasts (Hinz et al., 2001a) (Fig. 3 A; video available
at http://www.jcb.org/cgi/content/full/jcb.200201049/DC1).
At a concentration of 5–10 
 
 
 
g/ml, SMA-FP caused a release of
cellular tension as visualized by the reduction in the number of
wrinkles. This action was visible within 15 min (Fig. 3 B) and
maximal at 30 min (Fig. 3 C). Removing the SMA-FP reversed
this effect: after 10 min of washing, LFs first retracted as indi-
cated by a reduction of their area (Fig. 3 D). This was followed
by wrinkle reformation after 30–60 min (Fig. 3, E and F). The
cycle of wrinkle disappearance and reappearance was repeated
up to three times. SKA-FP and 
 
 
 
-CA–FP had no effect at all
concentrations tested (unpublished data).
Attached collagen lattices allow the quantitative assessment
of the contractile activity of cell populations when released
from the culture dish (Grinnell, 1994). LF-populated lattices
contracted rapidly, and after 30 min their diameters were re-
duced maximally to 58% of the initial diameter (Fig. 4, ct).
SKA-FP had no effect on lattice contraction (Fig. 4, SK, 250
 
 
 
g/ml). SMA-FP reduced lattice contraction concentration
dependently (Fig. 4 SM, from 56% at 5 
 
 
 
g/ml to 27% of the
initial diameter at 250 
 
 
 
g/ml). Washing out the SMA-FP be-
fore lattice release resulted in control contraction levels (Fig.
4, W). The specific inhibitory effect of SMA-FP on tension
production by LFs suggests a role of Ac-EEED in 
 
 
 
-SMA–
mediated myofibroblast contraction. Its reversibility indicates
that 
 
 
 
-SMA-FP does not affect significantly cell integrity.
Increased synthesis of extracellular matrix proteins is a
hallmark of myofibroblast activity (Serini and Gabbiani,
1999). To establish whether SMA-FP influences collagen
production, we incubated cultured LFs up to 5 d in medium
containing FPs at the concentration of 3–5 
 
 
 
g/ml. At the
end of this period, LFs maintained a shape similar to that of
untreated controls (Fig. 5). When cells were double stained
with 
 
 
 
-SMA antibody and phalloidin, 
 
 
 
-SMA stain was
practically abolished (Fig. 5 C), whereas phalloidin distribu-
tion remained similar to that of control LFs (Fig. 5, B and
D). Type I collagen mRNA expression evaluated by North-
ern blot started to decrease on the third day at all FP concen-
trations and was clearly lower than controls on the fifth day
(Fig. 6). Collagen mRNA changes were paralleled by a de-
crease of 
 
 
 
-SMA mRNA (Fig. 6). These results suggest that
the SMA-FP action on collagen and 
 
 
 
-SMA mRNA expres-
sion is exerted indirectly, for example through the decrease
of fibroblast-generated tension.
During the healing of a rat open wound, the level of
 
 
 
-SMA expressed de novo by myofibroblasts reaches a max-
imum in 9–10-d-old granulation tissue (Darby et al., 1990;
Hinz et al., 2001b). Strips cut from this tissue exert signifi-
cant isometric tension (130 
 
 
 
 23 
 
 
 
N) when stimulated
with SM agonists such as endothelin (ET)-1 (Majno et al.,
1971; Appleton et al., 1992; Hinz et al., 2001b). SMA-FP
(0.5 mg/ml) reversibly reduced the contractile activity of
granulation tissue strips to 36% compared with untreated
Figure 3. SMA-FP inhibits the tension 
exerted by LFs on silicone substrates. 
(A) Untreated LFs produce wrinkles on 
deformable silicone substrates during 60 
min recording. (B) Wrinkles decrease in 
number already 15 min after treatment 
with SMA-FP and completely disappear 
after 30 min (C). (D) 10 min after removal 
of the SMA-FP by repeated washing, LFs 
contract again followed by gradual 
wrinkle reformation after 30 (E) and 
60 min (F). Bar, 50  m. Also see the 
video available at http://www.jcb.org/
cgi/content/full/jcb.200201049/DC1.
Figure 4. SMA-FP inhibits LF-mediated contraction of collagen 
lattices. Attached collagen lattices were treated with FPs for 30 min 
and released; their diameter, measured after another 30 min, was 
normalized to the diameter before release (equals % contraction). 
Compared with untreated control lattices, (ct) SKA-FP (SK) has no 
effect on lattice contraction, whereas SMA-FP (SM) reduces contraction 
dose dependently; washing out SMA-FP before release (W) reverses 
this effect. *p   0.01 and **p   0.001 compared with control. 
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control strips or strips treated with the same concentration
of SKA-FP (Fig. 7). Thus, SMA-FP has the capacity of
inhibiting pharmacologically stimulated granulation tissue
myofibroblast contraction; the effective dose was approxi-
mately two orders of magnitude higher compared with in
vitro experiments, possibly due to the absorption of the FP
to the extracellular matrix.
To investigate the effect of SMA-FP on granulation tissue
contraction in vivo and to avoid as much as possible interfer-
ence with epithelialization, we have selected the model of
wounds splinted by means of a plastic frame (Abercrombie
et al., 1960; Hinz et al., 2001b). Compared with normal
healing wounds, the splinting technique increases the ex-
pression of 
 
 
 
-SMA by wound fibroblasts (Hinz et al.,
2001b). The mechanical prevention of wound contraction
accumulates tensile force that results in rapid wound area re-
 
duction when the frame is removed. In our experiments, the
frame was removed 10 d after wounding, and there was a re-
duction to 30% of the initial surface after 24 h (Fig. 8, A
and B). The splinted wounds were treated with carrier gel
alone and carrier gel containing either SKA-FP or SMA-FP
once on the eighth and ninth day and just after the removal
of the frame on the tenth day. 6 h after frame removal, the
area of control wounds and wounds treated with SKA-FP
was reduced to 
 
 
 
37% compared with the initial wound
area; application of SMA-FP significantly reduced this rapid
contraction (50% of the initial wound area) (Fig. 8, C and
D). After 24 h, control wound areas were further reduced to
31% of the initial wound area, whereas SMA-FP–treated
wounds exhibited significantly larger areas (42%).
 
Discussion
 
Our results show that the intracellular delivery of the 
 
 
 
-SMA
NH
 
2
 
-terminal peptide Ac-EEED, a sequence conserved in
mammalian species (Vandekerckhove and Weber, 1978), de-
creases specifically the tension exerted by myofibroblasts in
vitro and reduces granulation tissue contraction in vivo. They
support the hypothesis that 
 
 
 
-SMA through this sequence
plays a role in the production of tension by myofibroblastic
cells. They also support the possibility that actin isoforms ex-
ert specific activities (Chaponnier et al., 1995; Khaitlina,
2001). The selective disappearance of 
 
 
 
-CA staining from
stress fibers and the formation of protrusions observed in
these cells after administration of 
 
 
 
-CA–FP further reinforce
this assumption and suggest that the NH
 
2
 
-terminal sequence
of actin isoforms plays an important role in determining their
function. Our results showing a selective disappearance of
 
 
 
-SMA after the administration of SMA-FP and of 
 
 -CA af-
ter administration of  -CA–FP support previous findings re-
porting actin isoform segregation within the cytoplasm
(DeNofrio et al., 1989; Gimona et al., 1994) and, albeit
indirectly, the suggestion that stress fibers may contain actin
filaments composed of a single isoform (for review see Gun-
Figure 5. Long term effect of SMA-FP on LF morphology and  -SMA 
immunostaining. LFs grown for 5 d in enriched serum-free medium 
exhibit a highly organized stress fiber apparatus that stains for 
 -SMA (A, green) and F-actin (B, phalloidin red). Administration of 
SMA-FP twice a day for 5 d almost completely abolishes staining 
for  -SMA (C) but does not change cell morphology and F-actin 
distribution (D). Bar, 50  m.
Figure 6. SMA-FP decreases mRNA expression of collagen I and 
actin in cultured myofibroblasts. After treating cultured LFs with 
SMA-FP (3  g/ml) for 1–5 d, Northern blot analysis shows a time-
dependent decrease of collagen I mRNA, detected in two bands at 
4.7 and 5.8 kb, and of  -SMA, detected at 1.7 kb. In both cases, the 
decrease is visible on the third day. Control LFs (ct) do not show 
changes in collagen I and  -SMA mRNA after similar incubation 
times.
Figure 7. SMA-FP inhibits granulation tissue strip contraction. 
Strips from 9-d-old granulation tissue were stimulated with ET-1, 
returned to resting tension by washing for 120 min, then treated 
with FPs for 60 min or left untreated and stimulated a second time 
with ET-1. Reversibility was tested by washing 120 min and stimulat-
ing with ET-1 a third time. Treatment with SKA-FP (SK) does not 
change contraction compared with untreated strips (ct). SMA-FP 
(SM) significantly reduces strip contraction; washing out SMA-FP re-
stores control contraction levels. **p   0.001 compared with con-
trol.Ac-EEED peptide and myofibroblast contraction | Hinz et al. 661
ning et al., 1998). We have reported previously that microin-
jection of  -SMA antibody in myofibroblasts results in stress
fiber disappearance (Skalli et al., 1990); however, the mor-
phological results and the kinetics of changes were clearly dif-
ferent from the results described here.
The mechanism of collagen mRNA expression decrease in
SMA-FP–treated cells is presently not clear. It is conceivable
that tension reduction after the application of SMA-FP is in
turn responsible for the decrease of collagen and  -SMA
mRNA expression that takes place starting at 3 d after SMA-
FP application. The expression of  -SMA in myofibroblasts
has been shown recently to decrease with decreasing tension of
(a) collagen substrate in culture (Arora et al., 1999) and (b) rat
granulation tissue (Hinz et al., 2001b). Based on these find-
ings, we suggest that SMA-FP can exert beneficial effects on
excessive wound contraction and fibrocontractive diseases for
which no efficient pharmacological therapy exists at present.
The mechanism of tension generation by myofibroblasts
is not established. It is accepted that it depends on develop-
ment and organization of stress fibers (Burridge, 1981; To-
masek et al., 1992; Katoh et al., 1998). More and more evi-
dence is accumulating in favor of the possibility that the
incorporation of  -SMA in myofibroblast stress fibers is es-
sential for controlling the level of force production by these
cells (Arora and McCulloch, 1994; Hinz et al., 2001a). It is
noteworthy that the inhibition of myofibroblast contraction
in vitro and in vivo by SMA-FP was always partial. This is in
accordance with the possibility that stress fibers containing
only cytoplasmic actins exert a contractile activity and that
incorporation of  -SMA in stress fibers increases impor-
tantly their contractile force (Hinz et al., 2001a).
The expression of  -SMA and collagen and that of other
extracellular matrix components, such as ED-A fibronectin,
is stimulated coordinately by TGF- , a key factor in granu-
lation tissue evolution and development of fibrocontractive
diseases (Sporn and Roberts, 1992; Desmoulière et al.,
1993; Rønnov-Jessen and Petersen, 1993; Gauldie et al.,
1999); it will be important to study the effect of SMA-FP on
the expression and/or activation of this growth factor. Fur-
ther work is also required to (a) establish whether SMA-FP
acts through its effect on  -SMA polymerization (Chapon-
nier et al., 1995) and/or through a more direct influence on
actin-myosin–dependent force generation and (b) identify
an hypothetical SMA-FP partner at the level of the myofi-
broblast contractile apparatus.
In addition to providing new insight into cellular mecha-
nisms of contraction, our results present a strategy for (a) ex-
ploring the role of actin isoforms in cell and tissue activities,
(b) better understanding the mechanisms of stress fiber
function and of granulation tissue contraction, and (c) de-
veloping an hitherto unexplored approach to control tissue
remodeling during normal and pathological wound healing
and fibrocontractive diseases.
Materials and methods
Fusion peptides
SMA-FP, SKA-FP, and  -CA–FP, containing Ac-EEED, Ac-DEDE, and Ac-
DDDIA, respectively, at the NH2 terminus of the cell-penetrating vector
pAntp-Pro50 (Derossi et al., 1994), were synthesized to a purity of 95%
(UCB Bioproducts); this vector was chosen for its efficiency in cytoplasmic
delivery (Derossi et al., 1994). The two first FPs were also tagged with Rh B,
covalently linked through a tetra-Glycine arm with a lysine in position 5
(UCB Bioproducts). This did not change their activity. After preliminary ex-
periments, SMA-, SKA-, SMA-Rh-, and SKA-Rh-FP were added at the fol-
lowing concentrations if not stated otherwise: 3–10  g/ml to cultured cells
on plastic and silicone substrates, 5–250  g/ml to cells in collagen lattices,
500  g/ml to excised granulation tissue strips, and 500  g/ml carrier gel
(Lutrol
® F-127; BASF AG) in the treatment of in vivo wounds (see below for
experimental details).  -CA–FP was used at concentrations of 3–500  g/ml.
Figure 8. SMA-FP reduces in vivo wound contraction. (A) A repre-
sentative full thickness wound on the rat dorsal region was subjected 
to mechanical tension by splinting; the frame was left in place for 
10 d. The scab was removed 8 d after wounding, and wound tissue 
was treated with FPs in carrier gel or with carrier gel only. Treatment 
was repeated on the ninth and tenth day after wounding. (B) 24 h 
after splint removal, the wound treated with SKA-FP exhibits an 
important surface reduction comparable to that of untreated controls. 
(C) The wound treated with SMA-FP exhibits a significantly less 
important reduction. (D) Wound area was measured 6 and 24 h 
after splint removal and normalized to the initial wound area. Mean 
values were calculated using 20 animals per experimental condition. 
ct, carrier gel only; SK, SKA-FP; SM, SMA-FP. **p   0.001 compared 
with control.662 The Journal of Cell Biology | Volume 157, Number 4, 2002
In vitro experiments
LFs were isolated and cultured as described previously (Desmoulière et al.,
1992) and cultured for 4 d on 60-mm culture dishes (Nunc and Life Tech-
nologies) in MEM plus 10% FCS. Experiments were performed in serum-
free MEM to avoid FP precipitation. LFs were incubated with Rh-tagged
FPs, fixed with methanol, and stained for  -SMA (anti– SM-1, IgG2a
monoclonal antibody) (Skalli et al., 1986) and  -CA ( 74, rbAb) (Yao et
al., 1995) followed by the secondary antibodies goat anti–mouse FITC-
conjugated and goat anti–rabbit aminomethylcoumarin acetate- or Rh-
conjugated (Jackson ImmunoResearch Laboratories). Rh-phalloidin
(Molecular Probes) staining was performed after fixation with 3% para-
formaldehyde/PBS and permeabilization with 0.2% Triton X-100/PBS.
Mounted samples were observed with a 40  oil immersion objective on
an Axiophot microscope (ZEISS). Images were acquired with a digital color
camera and corresponding software (Axiocam; ZEISS). All images were
processed for printing with the use of Adobe Photoshop
®.
To visualize the contractile activity of single cells, LFs were cultured for
4 d in the presence of FCS on deformable silicone substrates (Harris et al.,
1980), which were produced in order to obtain an optimal resistance, as
previously described (Hinz et al., 2001a). Image sequences were obtained
with an inverted microscope (Axiovert 135; ZEISS) equipped with a 63 
objective B/W camera (BC-2; AVT Horn), frame grabber (Meteor PCI; Ma-
trox Electronic Systems Ltd.), and KS400 software (ZEISS). FPs were added
after 60 min control recording in serum-free MEM (see above) and subse-
quently removed by repeated washing in order to test reversibility.
Attached collagen lattices (Grinnell, 1994) were produced and mixed
with LFs (2.5   10
5/ml) as described previously (Hinz et al., 2001a) and
cultured for 5 d in MEM plus 10% FCS. Lattices were then treated with FPs,
released, and the measured diameter after 30 min was normalized to the
diameter before release (equals % contraction). Reversibility was tested by
washing the treated lattices before release.
RNA extraction and Northern blotting
LFs were grown to 80% confluence in 10-cm cell culture dishes in MEM
plus 10% FCS; cells were then cultured up to 5 d in enriched serum-free
medium (Stouffer and Owens, 1992) containing FPs at the concentration of
3–5  g/ml; the culture medium with FPs was changed twice a day. Total
RNA was isolated using Trizol reagent (Invitrogen) according to the manu-
facturer’s protocol. Total RNA (2.5–5.0  g per lane) was denatured, sepa-
rated by electrophoresis, and transferred onto an Electran nylon membrane
(BDH Laboratory Supplies) as described previously (Serini et al., 1998).
Hybridization was performed with two probes: a 1,600-bp rat  1(I) col-
lagen cDNA, recognizing two bands at 5.8 and 4.7 kb (Genovese et al.,
1984), and a 320-bp total actin cRNA (Kocher and Gabbiani, 1986), rec-
ognizing  -SMA mRNA at 1.7 kb and cytoplasmic actin mRNA at 2.1 kb as
described previously (Kocher and Gabbiani, 1986; Serini et al., 1998).
Quantification of the signal was normalized to results obtained using
GAPDH probe (Neuville et al., 1997). After hybridization, filters were
washed 2   20 min at 65 C (collagen) and 58 C (actin), respectively, in
5  SSC and 0.1% SDS. Northern blots were then exposed on Eastman
Kodak Co. X-Omat SO-282 film at  70 C.
Animal experiments
To measure isometric tension of excised granulation tissue strips, a total of
40 female Wistar rats (200–250 g) were used. All animal procedures were
performed according to Federal Veterinary Guideline and approved by the
Ethical Committee of the Geneva Medical Faculty. Full thickness 25   25-
mm wounds were made in the middle of the dorsum (Hinz et al., 2001b).
Rats were killed by CO2 anesthesia 9 d after wounding, and the tissue was
dissected and cut into strips of 5   10 mm. Strips were prestressed in an
organ bath on the levers of an isometric force displacement transducer
(FT03; Grass Instrument Co.) (Hinz et al., 2001b), stimulated with ET-1
(Bachem AG) 10
 7 M, returned to resting tension by washing for 120 min,
and then treated with FPs for 60 min or left untreated and stimulated a sec-
ond time with ET-1. Reversibility was tested by washing 120 min and stim-
ulating with ET-1 a third time. Peak tension was measured  30 min after
each stimulation, and mean values were calculated from three tissue strips
per animal and 10 animals per experimental condition as described previ-
ously (Hinz et al., 2001b).
To test in vivo wound contraction, a total of 80 female Wistar rats (200–
250 g) were used. Full thickness 25   25-mm wounds (see above) were
subjected to mechanical tension by splinting, that is, fixing their edges to a
plastic frame by means of surgical thread; the frame was left in place for 10 d
(Hinz et al., 2001b). The scab of splinted wounds was removed 8 d after
wounding, and wound tissue was treated with FPs in 1 ml of carrier gel
(Lutrol
® F-127; BASF AG) or with carrier gel only and was covered with a
transparent film (OpSite™; Smith & Nephew Medical Ltd.). Treatment was
repeated on the ninth and tenth day after wounding immediately after re-
moval of the splint. Wound area was measured immediately before remov-
ing the plastic frame and after 6 and 24 h. Wound contraction was calcu-
lated as area reduction normalized to the initial wound size. Mean values
were calculated using 20 animals per experimental condition.
Statistical analysis
Quantitative results are presented as mean values   SD. Differences be-
tween mean values were tested by means of a two-tailed heteroscedastic
Student’s t test and were considered to be statistically significant at values
of *p   0.01 and **p   0.001.
Online supplemental material
The video (available at http://www.jcb.org/cgi/content/full/jcb.200201049/
DC1) demonstrates the effect of the SMA-FP on the wrinkling capacity of
LFs on silicone substrates. The sequence starts with an untreated LF that
has already been observed for 60 min, producing wrinkles on a deform-
able silicone substrate without visible changes. After treatment with SMA-
FP, wrinkles gradually disappear within 30 min. After two washing steps,
the LF contracts again restoring wrinkles completely after 60 min. 
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